-
摘要:
目的 探讨微小核糖核酸(miRNA,miR)-155在大鼠肝移植术后排斥反应中的作用机制。 方法 将大鼠分为异系移植模型组(排斥组,n=10),供体为雄性Lewis大鼠,受体为雄性BN大鼠;同系移植模型组(对照组,n=10),供、受体均为雄性Lewis大鼠;两组均按照“二袖套法”建立大鼠原位肝移植模型。术后第7日处死大鼠取血标本和肝组织。检测肝功能指标丙氨酸转氨酶(ALT)、总胆红素(TB)以及细胞因子白细胞介素(IL)-2、IL-4、干扰素(IFN)-γ的水平;光学显微镜下观察肝组织的病理变化情况。对两组大鼠肝组织样本每组选取3例进行高通量测序,检测排斥反应相关miRNA,进行生物信息学分析,预测并分析其相关的信号通路以及基因。 结果 肝功能检测显示排斥组大鼠血清中ALT、TB水平均高于对照组,差异均有统计学意义(均为 P < 0.01)。外周血细胞因子检测显示,与对照组比较,排斥组的IL-2和IFN-γ水平升高(均为 P < 0.01),IL-4水平下降( P < 0.01)。病理检查结果提示,与对照组比较,排斥组发生了明显的排斥反应。高通量检测结果示排斥组miR-155表达上调明显,为对照组5.89倍。生物信息学分析提示,miR-155的上调表达与哺乳动物雷帕霉素靶蛋白(mTOR)、丝裂原活化蛋白激酶(MAPK)及T细胞受体信号通路有关,可能参与调节的基因有酵母自噬基因(ATG1)及其同源基因ULK2、胰岛素样生长因子-1(Igf-1)以及G蛋白偶联受体的调节基因(Arrb1)等。 结论 miR-155可能促进了大鼠肝移植术后排斥反应的发生发展,涉及此过程的信号通路可能有mTOR、MAPK信号通路及T细胞受体信号途径,ATG1、ULK2、Igf-1以及Arrb1等基因可能参与了此过程。 Abstract:Objective To explore the mechanism of microRNA (miRNA, miR)-155 in the rejection after liver transplantation in rats. Methods The rats were divided into two groups. In the xenograft model group (rejection group, n=10), the donors were male Lewis rats and the recipients were male BN rats. In the allograft model group (control group, n=10), both the donors and recipients were male Lewis rats. The rat models with orthotopic liver transplantation were established by two-cuff technique in two groups. At postoperative 7 d, the animals were sacrificed for the collection of blood and liver tissue samples. The serum levels of alanine aminotransferase (ALT), total bilirubin (TB), and cytokines of interleukin (IL)-2, IL-4, interferon (IFN)-γ were quantitatively measured. The pathological changes of liver tissues were observed under light microscope. In each group, three liver tissue samples were prepared and subject to high-throughput sequencing. The miRNAs related to rejection were identified for bioinformatics analysis to predict and analyze relevant signaling pathways and genes. Results In the rejection group, the serum levels of ALT and TB were significantly higher than those in the control group (both P < 0.01). Compared with the control group, the levels of IL-2 and IFN-γ were considerably up-regulated (both P < 0.01), whereas the level of IL-4 was dramatically down-regulated ( P < 0.01). Pathological examination demonstrated that more evident rejections were observed in the rejection group than the control group. High-throughput sequencing revealed that the expression level of miR-155 was significantly up-regulated in the rejection group, which was 5.89 times of that in the control group. Bioinformatics analysis demonstrated that up-regulation of miR-155 was associated with the mammalian target of rapamycin (mTOR), mitogen-activated protein kinase (MAPK) and T cell receptor signaling pathways. The genes which were probably responsible for regulation included the yeast autophagy related gene 1(ATG1) and its homologous gene ULK2, insulin-like growth factor-1 (Igf-1) and G protein-coupled receptor regulatory gene (Arrb1), etc. Conclusions miR-155 might promote the incidence and progression of rejection after liver transplantation in rats. The involved signaling pathways probably include the mTOR, MAPK signaling pathway and T cell receptor signaling pathway. ATG1, ULK2, Igf-1, and Arrb1 genes may participate in this process. -
表 1 两组大鼠肝移植术后7 d肝功能和细胞因子水平的比较
Table 1. Comparison of liver function and cytokine levels of rats between two groups at 7 d after liver transplantation((x±s))
指标 排斥组(n=10) 对照组(n=10) t值 P值 ALT(U/L) 289±40 64±16 16.37 < 0.01 TB(μmol/L) 26.1±5.3 4.9±1.6 12.11 < 0.01 IL-2(ng/L) 331±23 58±17 30.43 < 0.01 IL-4(ng/L) 088±24 231±170 24.67 < 0.01 IFN-γ(ng/L) 302±25 50±19 25.24 < 0.01 表 2 大鼠肝移植术后发生排斥反应中表达差异变化的miRNA
Table 2. The miRNA with differential changes during rejection after liver transplantation in rats
miRNA名称 FC( P < 0.05) 表达上调 rno-miR-155 5.89 rno-miR-146b 5.52 rno-miR-151 5.21 rno-miR-130b 4.87 rno-miR-140 4.78 rno-miR-223 4.59 rno-miR-101b 4.58 rno-miR-342-3p 4.37 rno-miR-128 4.24 rno-miR-674-5p 4.02 rno-miR-107 3.93 rno-miR-132 3.88 rno-miR-365 3.73 rno-miR-142-3p 3.71 rno-miR-16 3.23 rno-miR-7a 3.17 rno-miR-328 2.96 rno-miR-146a 2.73 rno-miR-15b 2.54 rno-miR-93 2.45 rno-miR-25 2.21 rno-miR-150 2.07 rno-miR-652 1.87 rno-miR-99b* 1.73 rno-miR-186 1.67 表达下调 rno-miR-194 0.05 rno-miR-375 0.05 rno-miR-31 0.06 rno-miR-30c 0.09 rno-miR-3752 0.11 rno-miR-668 0.14 rno-miR-505 0.15 rno-miR-210 0.19 rno-miR-490 0.21 rno-miR-193 0.24 rno-miR-122* 0.27 rno-miR-291a-5p 0.28 rno-miR-345-5p 0.31 rno-miR-874 0.36 rno-miR-434-3p 0.39 rno-miR-10b 0.40 rno-miR-22* 0.42 rno-miR-872* 0.49 rno-miR-802 0.53 rno-miR-338* 0.55 rno-miR-347 0.61 rno为大鼠 -
[1] 陈规划, 姜楠.肝移植免疫耐受的研究热点和思考[J].器官移植, 2017, 8(1): 1-4.DOI: 10.3969/j.issn.1674- 7445.2017.01.001.CHEN GH, JIANG N. Research focus and thinking of immune tolerance in liver transplantation[J]. Organ Transplant, 2017, 8(1): 1-4.DOI: 10.3969/j.issn.1674- 7445.2017.01.001.j.issn.1674-7445.2017.01.001. [2] LODHI SA, LAMB KE, MEIER-KRIESCHE HU. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic shortterm success[J]. Am J Transplant, 2011, 11(6): 1226- 1235. DOI: 10.1111/j.1600-6143.2011.03539.x. [3] 傅志仁, 施晓敏, 张晓君.肝移植术后免疫抑制剂的长期应用及其不良反应的控制[J].外科理论与实践, 2008, 13(4): 310-312. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=wkllysj200804010FU ZR, SHI XM, ZHANG XJ. Control of long-term adverse effects of immunosuppressor treatment after liver transplantation[J]. J Surg Conc Pract, 2008, 13(4): 310-312. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=wkllysj200804010 [4] 吴永璐, 陈洁. MicroRNAs表达在泌尿系肿瘤中的研究进展[J].实用医学杂志, 2017, 33(3): 490-492. DOI: 10.3969/j.issn.1006-5725.2017.03.043.WU YL, CHEN J. Research progress of microRNAs expression in urological tumors[J]. J Pract Med, 2017, 33(3): 490-492. DOI: 10.3969/j.issn.1006-5725.2017.03.043. [5] PALIN AC, RAMACHANDRAN V, ACHARYA S, et al. Human neonatal naive CD4+ T cells have enhancedactivation-dependent signaling regulated by the microRNA miR-181a[J]. J Immunol, 2013, 190(6): 2682-2691. DOI: 10.4049/jimmunol.1202534. [6] HU J, WANG Z, TAN CJ, et al. Plasma microRNA, a potential biomarker for acute rejection after liver transplantation[J]. Transplantation, 2013, 95(8): 991- 999. DOI: 10.1097/TP.0b013e31828618d8. [7] MITCHELL PS, PARKIN RK, KROH EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection[J]. Proc Natl Acad Sci U S A, 2008, 105(30): 10513-10518. DOI: 10.1073/pnas.0804549105. [8] K A M A D A N, C A L N E RY. O r t h o t o p i c l i v e r transplantation in the rat. technique using cuff for portal vein anastomosis and biliary drainage[J]. Transplantation, 1979, 28(1): 47-50. doi: 10.1097/00007890-197907000-00011 [9] WA N C D, C H E N G R, WA N G H B, et al. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(1):29-33. http://www.hbpdint.com/EN/abstract/abstract3129.shtml [10] SARKAR N, PANIGRAHI R, PAL A, et al. Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes[J]. J Viral Hepat, 2015, 22(10): 817-827. DOI: 10.1111/jvh.12390. [11] BALA S, PETRASEK J, MUNDKUR S, et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, andinflammatory liver diseases[J]. Hepatology, 2012, 56(5): 1946-1957. DOI: 10.1002/hep.25873. [12] KUNDROTAS G, GASPERSKAJA E, SLAPSYTE G, et al. Identity, proliferation capacity, genomic stability and novel senescence markers of mesenchymal stem cells isolated from low volume of human bone marrow[J]. Oncotarget, 2016, 7(10): 10788-10802. DOI: 10.18632/oncotarget.7456. [13] WEI L, WANG M, QU X, et al. Differential expression of microRNAs during allograft rejection[J]. Am J Transplant, 2012, 12(5): 1113-1123. DOI: 10.1111/j.1600- 6143.2011.03958.x. [14] FARID WR, PAN Q, VAN DER MEER AJ, et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation[J]. Liver Transpl, 2012, 18(3): 290-297. DOI: 10.1002/lt.22438. [15] WANG Y, TIAN Y, DING Y, et al. MiR-152 may silence translation of CaMK Ⅱ and induce spontaneous immune tolerance in mouse liver transplantation[J]. PLoS One, 2014, 9(8): e105096. DOI: 10.1371/journal.pone.0105096. [16] RODRIGUEZ A, VIGORITO E, CLARE S, et al. Requirement of bic/microRNA-155 for normal immune function[J]. Science, 2007, 316(5824): 608-611. DOI: 10.1126/science.1139253.